Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
2.200
+0.150 (7.32%)
At close: Oct 15, 2025, 4:00 PM EDT
1.890
-0.310 (-14.09%)
Pre-market: Oct 16, 2025, 6:06 AM EDT
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $172.88 million as of October 16, 2025. Its market cap has increased by 128.89% in one year.
Market Cap
172.88M
Enterprise Value
147.71M
1-Year Change
128.89%
Ranking
Category
Stock Price
$2.20
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $172.88M, an increase of 283.79%. That is a compound annual growth rate of 33.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 161.09M | 150.94% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
| Jan 27, 2021 | 45.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.04B |
| Johnson & Johnson | 460.40B |
| AbbVie | 399.63B |
| UnitedHealth Group | 327.08B |
| AstraZeneca | 262.65B |
| Novartis AG | 252.43B |
| Novo Nordisk | 251.88B |
| Abbott Laboratories | 225.30B |